Publications by authors named "Maria Teresa Saliani"
Article Synopsis
- HArmonyCa™ is a new hybrid dermal filler combining hyaluronic acid and calcium hydroxylapatite, aimed at improving facial aging and skin conditions.* -
- The study involved 129 patients who underwent HArmonyCa™ treatment, with outcomes evaluated nine months post-treatment using both physician and patient satisfaction assessments.* -
- Results indicated significant improvements in facial appearance and movement, with only minor adverse effects reported, demonstrating the treatment's safety and compatibility with other cosmetic interventions.*
Plasma exchange has been proposed as support therapy in both acute and chronic forms of multiple sclerosis (MS). For the first time, we aimed to assess whether double filtration plasmapheresis (DFPP) could be clinically efficacious. We describe the case of a patient affected by MS who developed a severe crisis refractory to conventional steroids, and immunosuppressive and immunomodulating therapy.
View Article and Find Full Text PDFSudden hearing loss (SHL) is a highly disabling affliction that can severely affect the subject's social and relational life. Although the etiology of the complaint is still debated, it is thought that microcirculation disturbances conditioned by an endothelial dysfunction might be the main pathogenetic mechanism. Adhesion molecules favoring interaction between leukocytes and endothelial cells are early markers of endothelial damage.
View Article and Find Full Text PDFNonarteritic acute anterior ischemic optic neuropathy (NAION) is a disabling disease which impairs visual function. It is presumed to result from disturbances of microcirculation in the anterior portion of the optic nerve head due to hemodynamic factors derived from excessive blood viscosity, or restriction of the vasal lumen in hypertensive, hypercholesterolemic, diabetic patients. We aimed to determine whether acute reduction of plasma fibrinogen and serum low-density lipoprotein (LDL) cholesterol is effective for treatment of NAION.
View Article and Find Full Text PDFArticle Synopsis
- Activation of the renin-angiotensin system (RAS) may increase renal vascular resistance (RVR) and contribute to hypertension in autosomal dominant polycystic kidney disease (ADPKD) patients.
- A study involving 34 ADPKD patients, divided into hypertensive and normotensive groups, found that plasma renin activity (PRA) was normal in both groups, but RVR was significantly higher in hypertensive patients.
- The results indicate a strong correlation between RVR and mean arterial pressure (MAP), suggesting that factors other than RAS are likely involved in early hypertension development in ADPKD patients without renal impairment.